General gynaecological presentations out of scope

​​​​Public outpatient services in NSW are generally not provided to patients presenting with these conditions.

Adult patients (aged 16 years or over)

Presenting conditionOut of scope (not routinely provided) criteria
Abnormal cervical screening
  • Positive human papillomavirus (HPV) not 16/18 with a
    normal liquid-based cytology (LBC) or pLSIL/LSIL on 1 test
  • Post-coital bleeding on 1 occasion
    Note: recommended that general practitioner collects co-test
  • Undergoing test of cure
Abnormal uterine bleeding
  • Histopathologically confirmed genital tract malignancy
    Note: referral to gynaecological oncology is indicated, where available
  • Uncomplicated (i.e. normal haemoglobin, normal pelvic ultrasound, negative cervical screening test) heavy menstrual bleeding where there is no trial of first-line treatment
Dysmenorrhoea
  • Dysmenorrhoea for < 3 months
  • Single presentation with dysmenorrhoea
Pelvic mass
  • Asymptomatic fibroids < 8 cm
  • Asymptomatic simple ovarian cyst < 5 cm on pelvic ultrasound in pre-menopausal patient
  • Persistent, asymptomatic simple ovarian cyst < 5 cm on two pelvic ultrasounds performed 6-12 weeks apart in pre-menopausal patient and normal CA-125
    Note: annual ultrasound in primary care is recommended for monitoring
Persistent pelvic pain
Post-coital bleeding
  • Histopathologically confirmed genital tract malignancy
    Note: referral to gynaecological oncology is indicated, where available
  • Known genital tract malignancy undergoing treatment
  • Post coital bleeding that ceases following treatment of chlamydia or gonorrhoea infection
  • Single episode of post-coital bleeding with normal cervical screening test and liquid based cytology (LBC) without oncogenic human papillomavirus (HPV)
Post-menopausal bleeding
  • Expected, regular withdrawal bleed in patient taking cyclical menopausal hormonal therapy (MHT)
  • < 12 months since last menstrual period
    Note: refer to abnormal uterine bleeding SRC for more information
  • Single episode of bleeding with endometrial thickness < 4 mm on transvaginal pelvic ultrasound and negative cervical screening result
Prolapse
  • Asymptomatic prolapse
  • Obstructive defecation associated with rectal prolapse
    Note: referral to colorectal surgeon is indicated
  • Prolapse where the symptoms are well-controlled with a vaginal pessary and patient does not desire surgery
  • Recurrent urinary tract infections not directly attributable to pelvic organ prolapse
Urinary incontinence
  • < 6 weeks from a gynaecological procedure
    Note: recommended to seek advice from treating doctor
  • Post-partum < 6 weeks with overflow incontinence
  • Urinary incontinence as a complication of poorly controlled diabetes (i.e. neurogenic bladder)
    Note: referral to urologist is indicated
  • Urinary tract malignancy
    Note: referral to urologist may be indicated
Vulval disorders
  • Any skin abnormality that is part of a widespread skin disorder
    Note: referral to dermatologist is indicated
  • Cosmetic vulval procedures and any associated complications (e.g. labioplasty)
  • Histopathologically confirmed genital tract malignancy
    Note: referral to gynaecological oncology is indicated, where available
Non-condition specific
  • Cosmetic genital surgery or elective cosmetic surgery
  • Experienced one miscarriage
  • Gender affirming surgery of all types
  • Heavy menstrual bleeding where there is no trial of first-line treatment
  • Chronic pelvic pain without trial of 1st line treatment
  • Post-natal check-up
  • Recurrent, simple ovarian cysts in patients who have not tried hormonal contraception
  • Reversal of tubal ligation
  • Routine cervical screening (unless access to cervix is difficult)
  • Routine contraceptive counselling
  • Routine diagnosis and management of polycystic ovarian syndrome (PCOS)
  • Routine gynaecological check-up
  • Routine Implanon/Mirena/progesterone-releasing intrauterine device (IUD) insertion for contraception, or removal
    Note: exception applies where general anaesthetic is required for insertion and/or removal
  • Uncomplicated sexually transmitted infections
  • Vulval disorders without a trial or 1st line treatment

Current as at: Monday 23 March 2026
Contact page owner: System Purchasing